SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CollaGenex (CGPI) FDA PENDING
CGPI 0.00010000.0%Jul 21 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BRIAN P. BIRNER who wrote (13)9/24/1997 10:04:00 PM
From: Tom D   of 142
 
I would suggest you call Investor Relations.

I don't think the mouth rinse will impact the share price. I think that Periostat is the whole game.

I am frankly unhappy that the FDA left Collagenex hanging for a year before informing them that there was something wrong with the way the data were formatted. I sold my Collagenex recently. I din't want to do this. I wanted to be a long-term investor. My first lots were bought at 6 1/2 on July 16, 1996 (the nadir of the correction). But I don't want to be left holding the bag if the upcoming meeting with the FDA results in CGPI being required to do additional trials.

Its hard to believe that this could be the case, after all were just dealing with tetracycline. There can't be any safety issues. But maybe there is an efficacy concern. Anyway, if the news from this meeting is OK I will buy back in. But Collagenex was supposed to be one of my lowest risk biotech stocks, so I will sit on the sidelines for a few weeks. I hope the FDA isn't going to hurt us.

Good luck,

Tom D.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext